Dr. Alan S Brau M.D.

Recommended Articles

• Causes of Lung Nodules

  What are lung nodules?Lung nodules are spots present on the lung. These spots are usually around 1.5 inches or three centimeters in diameter. Lung nodules seen on imaging tests are often called as coin lesions. If a lung X-ray shows spots that are more than three centimeters, it is regarded as a...

• How Family Can Be a Powerful Support System for Those with Cystic Fibrosis

  Family can be a powerful support system. People are naturally community-driven beings who are healthiest and happiest when belonging to something greater. It's the reason that people will make great sacrifices for the people they love. Family can provide the pillar for emotional support through...

• The Link Between Childhood Asthma and COPD

  It is clear that smoking is one of the greatest risks for chronic obstructive pulmonary disease (COPD); however, there are other factors, such as second hand smoking (wherein you get the effects of smoking by getting exposed to it even if you do not smoke), contact with pollution, genetic...

• Cough Medicine for Cystic Fibrosis

  Medications for cystic fibrosis can help control the mucus in the lungs and keep the lungs’ normal functioning as much as possible. What is Cystic Fibrosis?Cystic fibrosis is a genetic disease known to affect the cells that make mucus, digestive fluids, and sweat. Usually, these fluids are thin...

• Laryngitis: What Is Croup?

  What is laryngitis?Laryngitis is the swelling of your voice box. It is often caused by an infection, mostly by a virus. The voice box is also known as the larynx. It links the back of your throat to the windpipe. The vocal cord and larynx are part and parcel and are required for speech. Laryngitis...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...